tiprankstipranks
Cantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
PremiumThe FlyCantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
4M ago
Pnt Biopharma Global put volume heavy and directionally bearish
PremiumThe Fly
Pnt Biopharma Global put volume heavy and directionally bearish
4M ago
Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls
4M ago
Lantheus, Point Biopharma report SPLASH trial met primary endpoint
PremiumThe FlyLantheus, Point Biopharma report SPLASH trial met primary endpoint
4M ago
Lantheus, Point Biopharma report topline results from Phase 3 SPLASH trial
PremiumThe Fly
Lantheus, Point Biopharma report topline results from Phase 3 SPLASH trial
4M ago
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
PremiumPress Releases
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
4M ago
Eli Lilly extends tender offer to acquire Point Biopharma for $12.50 per share
PremiumThe FlyEli Lilly extends tender offer to acquire Point Biopharma for $12.50 per share
5M ago
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
PremiumPress Releases
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
5M ago
Eli Lilly receives NRC consent regarding proposed Point Biopharma acquisition
PremiumThe Fly
Eli Lilly receives NRC consent regarding proposed Point Biopharma acquisition
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100